PHASTAR, UK Statistics CRO, Expands Into US
![](https://cdn.nwe.io/files/x/7f/e1/937b1675320f27619edc185daf75.jpg)
London, UK, October 26, 2015 (Newswire.com) - PHASTAR Inc. has been incorporated in the US and will start offering industry leading statistical and medical writing services from a US base within the next few weeks.
PHASTAR has headquarters in London, UK and three regional additional UK offices (Manchester, Glasgow, Canterbury). The company started in 2007 offering specialist statistical services to pharmaceutical and biotech companies with a focus on providing the highest quality statistical advice and data analysis. Satisfied customers have fuelled substantial growth, and the company is currently in the running to be one of the top 100 fastest growing companies in the UK.
We are looking forward to demonstrating to US pharma and biotech companies why we have grown so rapidly in the UK. Statistics is an art - there are so many different ways to design and analyse clinical trials - and not many of our competitors demonstrate agility in this area.
Kevin Kane, CEO and Founder of PHASTAR
The first US office for PHASTAR will be based in Research Triangle Park, North Carolina. An experienced US based management team has been lined up to be the cornerstones of PHASTAR's North American business. The statistics and programming teams in the US will expand to complement the growing UK business and the four existing UK offices. Recruitment for experienced statisticians and programmers to be based in the North Carolina offices will start immediately (send resumes to recruitment@phastar.co.uk).
The US branch of the company will grow with a common culture based on the company's existing values: to provide the highest quality services in statistics, programming and medical writing, and to be a fun and stimulating company to work for. PHASTAR plans to become a significant player in the delivery of statistical and medical writing services for the US market.
More details regarding the US management team will be released in the next few weeks.